Systematic review and meta-analysis of molecular tumor board data on clinical effectiveness and evaluation gaps
Abstract Molecular Tumor Boards (MTBs) are pivotal in personalized cancer care. This systematic review and meta-analysis included 34 studies out of 576 articles (2020–January 2024) involving 12,176 patients across 26 major cancer entities. Of these, 20.8% (2,532 patients) received MTB-recommended th...
Saved in:
| Main Authors: | Beryl Primrose Gladstone, Janina Beha, Arisa Hakariya, Pavlos Missios, Nisar P. Malek, Michael Bitzer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-025-00865-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retrieval Augmented Therapy Suggestion for Molecular Tumor Boards: Algorithmic Development and Validation Study
by: Eliza Berman, et al.
Published: (2025-03-01) -
Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion
by: Nadja Ballin, et al.
Published: (2025-04-01) -
Signalomics for molecular tumor boards and precision oncology of breast and gynecological cancers
by: Tatiana V Denisenko, et al.
Published: (2025-06-01) -
User-centered design approach to visualize PROMs for molecular tumor boards
by: Sara Bäcker, et al.
Published: (2025-08-01) -
The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classification
by: K. Rahmani Narj Abadi, et al.
Published: (2024-12-01)